Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Adrenocortical Carcinoma 1Adrenal Gland Neoplasms 1

Interventions

Cisplatin 7Mitotane 5Doxorubicin 5Etoposide 4relacorilant 2Trastuzumab 2Cytoreduction Surgical Procedures 2tipifarnib 1sodium thiosulfate 1pembrolizumab 1pegfilgrastim 1iodophenyl metomidate 1gossypol acetic acid 1entinostat 1cixutumumab 1avelumab 1Vincristine 1Tamoxifen 1TKM-080301 1Suramin 1Sunitinib 1Streptozocin 1Radiotherapy 1Platinum 1Oxaliplatin 1Observation 1N-Ac-CHAVC-NH2 1N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride 1Microscopy, Electron 1Interleukin-12 Subunit p35 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adrenocortical Carcinoma × iodophenyl metomidate × Clear all
NCT00454103 2010-08-18

Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy

University of Wuerzburg

Phase 1/2 Completed
Endocrine

Adrenal Gland Neoplasms, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡